Long-term outcomes of Japan-specific dosage of rivaroxaban in high-risk patients with non-valvular atrial fibrillation: analysis from the XAPASS
Authors: T Ikeda, S Ogawa, T Kitazono, J Nakagawara, K Minematsu, S Miyamoto, Y Murakawa, S Iwashiro, Y Hayashi, Y Okayama, T Sunaya, S Sato, S Yamanaka